150 results
Page 4 of 8
8-K
EX-10.7
of0s450oecd3 ru
9 Apr 20
Aravive Announces Board Composition and Executive Management Transitions
4:43pm
8-K
EX-10.1
7jo 0rn5es
9 Apr 20
Aravive Announces Board Composition and Executive Management Transitions
4:43pm
8-K
EX-99.2
q4kf5n 3q7t
27 Mar 20
AVB-500 Phase 1b dose escalation ongoing at 20 mg/kg dose in platinum resistant ovarian cancer with potential for topline data in summer 2020
8:05am
8-K
EX-99.2
vikqk8c5ak6gs6s7q
18 Feb 20
Aravive Announces Dose Escalation of AVB-500 in Recurrent Platinum Resistant Ovarian Cancer Phase 1b Trial
8:10am
8-K
EX-99.1
6z611s8zm1zux
13 Jan 20
Other Events
8:06am
8-K
EX-10.3
1cz8iv9czjm
9 Jan 20
Aravive Announces Management Changes
4:59pm
8-K
EX-10.1
ybo 5ghzo8qrb
9 Jan 20
Aravive Announces Management Changes
4:59pm
8-K
EX-99.1
36wsezm9
2 Dec 19
Other Events
5:18pm
424B5
knes gw48idfai
27 Nov 19
Prospectus supplement for primary offering
4:07pm
424B5
lu9oh7v4w9p7gqf
26 Nov 19
Prospectus supplement for primary offering
5:18pm
8-K
EX-99.2
jg2kv0voy3dl
20 Nov 19
Other Events
7:05am
8-K
EX-99.1
as4dny193oytwv qac60
3 Oct 19
Other Events
7:15am
8-K
EX-99.2
qk0yd noz
27 Sep 19
Other Events
10:15am